Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYCLOPHARM LIMITED Director's Dealing 2021

Feb 23, 2021

64741_rns_2021-02-23_0049cd04-6d37-489c-9bef-3a028fbfa7eb.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Cyclopharm Limited
ABN 74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Thomas ArthurMcDONALD
Date of last notice 22 October 2020

Part 1 ‐ Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and indirect interest
Nature of indirect interest
**(including registered holder) ** Mrs. R McDonald
Note: Provide details of the circumstances giving rise
to the relevant interest.
< spouse of Non-Executive Director >
Date of change 19 February 2021
No. of securities held prior to change 43,214
Class Ordinary Shares
Number acquired 12,015
Number disposed Nil
Value/Consideration $31,238.00
Note: If consideration is non-cash, provide details and
estimated valuation
No. of securities held after change 27,914Mrs. R McDonald
< spouse of Non-Executive Director >
27,315Investment Administration Services
Pty Ltd< DIY Master Thomas McDonald>
55,229Total
Nature of change
Example: on-market trade, off-market trade, exercise
of options, issue of securities under dividend
reinvestment plan, participation in buy-back
Issue of shares in connection with Share
Purchase Plan
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil
Nature of interest Nil
Name of registered holder Nil
(if issued securities)
Date of change Nil
No. and class of securities to which interest related Nil
prior to change
Note: Details are only required for a contract in relation to which the
interest has changed
Interest acquired Nil
Interest disposed Nil
Value/Consideration Nil
Note: If consideration is non-cash, provide details and an estimated
valuation
Interest after change Nil

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts No
detailed above traded during a +closed period where
prior written clearance was required ?
If so, was prior written clearance provided to allow Not Applicable
the trade to proceed during this period ?
If prior written clearance was provided, on what date Not Applicable
was this provided ?
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2